Kasturi R, Yatsu F M, Alam R, Rogers S
University of Texas Medical School, Houston 77030.
Stroke. 1992 Sep;23(9):1257-64. doi: 10.1161/01.str.23.9.1257.
The presence of known restriction fragment length polymorphisms in the apoprotein A-I-C-III gene cluster, which encodes their respective apoproteins, was investigated using the restriction enzymes Sac I and Pst I to determine the potential role of genetic variations for stroke risk in an American population.
Ninety-eight subjects (70 white, 28 black subjects), both normal controls with no carotid stenosis and those with carotid stenosis believed at risk for stroke, defined as showing stenosis focally or diffusely at that site, composed the study population.
Sac I polymorphic S2 allele frequency was higher in stroke-risk groups, whereas Pst I polymorphic P2 allele frequency was similar in control and stroke-risk groups. Significantly higher levels of serum cholesterol, triglycerides, and low density lipoprotein (p less than 0.05) and significantly lower levels of high density lipoprotein (p less than 0.05) were observed in stroke-risk groups with diffuse stenosis. Results of our study with the two racial groups show the following: the frequency of Sac I polymorphism was significantly higher in American black compared with American white subjects (chi 2 = 3.92, p less than 0.05). Among serum lipids, triglycerides were significantly higher in white compared with black subjects (p less than 0.05). In white subjects, carotid artery stenosis was associated with significantly elevated total cholesterol and low density lipoprotein (p less than 0.01) but not with Sac I polymorphism. In black subjects the converse was observed, namely, the Sac I polymorphic S2 allele seemed to be associated with carotid bifurcation stenosis but did not reach statistical significance because of the small number of subjects. In addition, Sac I polymorphism did not correlate with any lipid profile. Pst I polymorphism was not associated with any lipid profile or carotid artery stenosis abnormalities.
Our results indicate that carotid artery stenosis identifies white subjects with increased plasma total cholesterol and low density lipoprotein, an atherogenic profile, but not with Sac I polymorphism. These findings suggest that carotid bifurcation stenosis in white subjects is associated with an atherogenic lipid profile but not with apoprotein A-I-C-III restriction fragment length polymorphisms. In black subjects, Sac I polymorphism seems to identify those individuals with significant carotid stenosis, a necessary precursor to atherothrombotic brain infarction, but not those with elevated total cholesterol, elevated low density lipoprotein, and/or reduced high density lipoprotein. These results suggest that Sac I polymorphism may identify black subjects at increased risk for atherothrombotic brain infarctions.
利用限制性内切酶Sac I和Pst I研究载脂蛋白A-I-C-III基因簇(该基因簇编码各自的载脂蛋白)中已知的限制性片段长度多态性的存在情况,以确定美国人群中基因变异对中风风险的潜在作用。
98名受试者(70名白人、28名黑人)组成了研究人群,其中包括无颈动脉狭窄的正常对照组以及被认为有中风风险的颈动脉狭窄患者(即该部位存在局灶性或弥漫性狭窄)。
中风风险组中Sac I多态性S2等位基因频率较高,而Pst I多态性P2等位基因频率在对照组和中风风险组中相似。在弥漫性狭窄的中风风险组中,血清胆固醇、甘油三酯和低密度脂蛋白水平显著升高(p<0.05),高密度脂蛋白水平显著降低(p<0.05)。我们对两个种族群体的研究结果如下:美国黑人中Sac I多态性频率显著高于美国白人(卡方=3.92,p<0.05)。在血脂方面,白人的甘油三酯水平显著高于黑人(p<0.05)。在白人受试者中,颈动脉狭窄与总胆固醇和低密度脂蛋白显著升高相关(p<0.01),但与Sac I多态性无关。在黑人受试者中观察到相反的情况,即Sac I多态性S2等位基因似乎与颈动脉分叉狭窄相关,但由于受试者数量较少未达到统计学意义。此外,Sac I多态性与任何血脂谱均无相关性。Pst I多态性与任何血脂谱或颈动脉狭窄异常均无关联。
我们的结果表明,颈动脉狭窄可识别出血浆总胆固醇和低密度脂蛋白升高(一种致动脉粥样硬化的特征)的白人受试者,但与Sac I多态性无关。这些发现表明,白人受试者的颈动脉分叉狭窄与致动脉粥样硬化的血脂谱相关,但与载脂蛋白A-I-C-III限制性片段长度多态性无关。在黑人受试者中,Sac I多态性似乎可识别出那些有显著颈动脉狭窄(动脉粥样硬化性脑梗死的必要先兆)的个体,但不能识别出总胆固醇升高、低密度脂蛋白升高和/或高密度脂蛋白降低的个体。这些结果表明,Sac I多态性可能识别出动脉粥样硬化性脑梗死风险增加的黑人受试者。